BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10474727)

  • 1. The hibernating heart: reversible left ventricular dysfunction in chronic heart failure.
    Burn S; Walters M; Caplin J
    Postgrad Med J; 1999 Jul; 75(885):419-21. PubMed ID: 10474727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of hibernating myocardium in patients with heart insufficiency].
    La Canna G; Agricola E; Alfieri O
    Ital Heart J Suppl; 2000 Oct; 1(10):1289-97. PubMed ID: 11068710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stunning, hibernation, and heart failure in patients with coronary disease: crucial role of impaired coronary flow reserve].
    Montano M; Camici PG
    Ital Heart J Suppl; 2003 Sep; 4(9):727-32. PubMed ID: 14635390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From coronary artery disease to heart failure: role of the hibernating myocardium.
    Rahimtoola SH
    Am J Cardiol; 1995 Apr; 75(13):16E-22E. PubMed ID: 7726119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hibernation and heart failure.
    Camici PG
    Heart; 2004 Feb; 90(2):141-3. PubMed ID: 14729778
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial Viability Testing to Guide Coronary Revascularization.
    Löffler AI; Kramer CM
    Interv Cardiol Clin; 2018 Jul; 7(3):355-365. PubMed ID: 29983147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease.
    Conversano A; Walsh JF; Geltman EM; Perez JE; Bergmann SR; Gropler RJ
    Am Heart J; 1996 Mar; 131(3):440-50. PubMed ID: 8604622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefit of noninvasive viability studies of patients with severe ischemic left ventricular dysfunction.
    Soto JR; Beller GA
    Clin Cardiol; 2001 Jun; 24(6):428-34. PubMed ID: 11403503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hibernation and congestive heart failure.
    Dutka DP; Camici PG
    Heart Fail Rev; 2003 Apr; 8(2):167-73. PubMed ID: 12766496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [F-18 fluorodeoxyglucose for diagnosis of myocardial viability: applications in clinical practice].
    Graf S; Porenta G
    Wien Med Wochenschr; 2002; 152(11-12):289-92. PubMed ID: 12138658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of diagnosing hibernating myocardium: how and in whom?
    Rahimtoola SH
    J Am Coll Cardiol; 1997 Dec; 30(7):1701-6. PubMed ID: 9385896
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible left ventricular dysfunction: does it affect clinical practice and does it matter?
    Redwood SR; Ferrari R; Marber MS
    Int J Clin Pract; 1998 Jun; 52(4):249-53. PubMed ID: 9744150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial viability: contractile reserve or cell membrane integrity?
    Dilsizian V
    J Am Coll Cardiol; 1996 Aug; 28(2):443-6. PubMed ID: 8800123
    [No Abstract]   [Full Text] [Related]  

  • 15. The identification of myocardial hibernation in patients with ischemic heart failure by echocardiography and radionuclide studies.
    Perrone-Filardi P; Chiariello M
    Prog Cardiovasc Dis; 2001; 43(5):419-32. PubMed ID: 11251128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability in patients with coronary artery disease and left ventricular dysfunction: transplantation or revascularization?
    DeNofrio D; Loh E
    Curr Opin Cardiol; 1996 Jul; 11(4):394-402. PubMed ID: 8879950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hibernating myocardium.
    Wijns W; Vatner SF; Camici PG
    N Engl J Med; 1998 Jul; 339(3):173-81. PubMed ID: 9664095
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles.
    al-Mohammad A; Mahy IR; Norton MY; Hillis G; Patel JC; Mikecz P; Walton S
    Heart; 1998 Dec; 80(6):559-64. PubMed ID: 10065022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular magnetic resonance imaging for detection of myocardial viability in chronic ischemic left ventricular dysfunction.
    Glaveckaite S; Valeviciene N; Laucevicius A; Celutkiene J; Rudys A; Tamosiūnas A
    Medicina (Kaunas); 2009; 45(8):585-99. PubMed ID: 19773617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
    D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.